AEON Biopharma, Inc. - Class A Common Stock (AEON)

Historical Holders from Q3 2023 to Q4 2024

Symbol
AEON on NYSE
CUSIP
00791X100
Type / Class
Equity / Class A Common Stock
Shares outstanding
39.7M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
8.88M
Holdings value
$4.8M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
36
Number of buys
16
Number of sells
-11
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of AEON Biopharma, Inc. - Class A Common Stock (AEON)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
L1 Capital Global Opportunities Master Fund, Ltd. 9.99% $627K 8.96M L1 Capital Global Opportunities Master Fund, Ltd. Jan 6, 2025
S.H.N. Financial Investments Ltd. 6% $378K 5.4M S.H.N. Financial Investments Ltd. Jan 6, 2025
BIGGER CAPITAL FUND L P 6.1% $343K 4.9M Bigger Michael Jan 6, 2025
Blue Owl Capital Holdings LP 3.81% $213K 3.05M Blue Owl Capital Holdings LP Dec 31, 2024
Polar Asset Management Partners Inc. 6.9% $193K 2.76M Polar Asset Management Partners Inc. Dec 31, 2024
PALMISANO ROBERT J 5.7% 0% $159K 2.27M 0% Robert J Palmisano Jul 25, 2024

Institutional Holders of AEON Biopharma, Inc. - Class A Common Stock (AEON)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q4 8.88M $4.8M -$378K $0.54 36
2024 Q3 9.57M $10.1M +$4.02M $1.05 30
2024 Q2 9.42M $8.73M -$432K $1.05 25
2024 Q1 9.47M $103M +$9.24M $11.60 26
2023 Q4 8.67M $56.8M +$26.5M $7.20 20
2023 Q3 4.75M $25.9M +$24.4M $5.60 15